Clinical Trials Browser

Prostatic Neoplasms × LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- × Clear all

NCT06613100 2026-05-14

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms

NCT06528210 2025-09-23

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT03876912 2021-04-13

ADTPSMA2

Phase NA Unknown

Prostatic Neoplasms

NCT03313726 2017-10-18

ADTPSMA

Phase NA Unknown

Prostatic Neoplasms